Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells

Molecular Carcinogenesis

Volumn 51, Issue 12, 2012, Pages 963-972

  Ting, C M ^a   Wong, Chris K C ^a   Wong, R N S ^a   Lo, K W ^b   Lee, Anne W M ^c   Tsao, George S W ^d   Lung, Maria L ^d   Mak, N K ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

2 methoxyestradiol; Bcl 2 xL; Endoreduplication; Nasopharyngeal carcinoma; STAT3 5

Indexed keywords

2 METHOXYESTRADIOL; DOCETAXEL; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PACLITAXEL; PHOSPHOPROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN INHIBITOR; SMALL INTERFERING RNA; STAT3 PROTEIN; STAT5 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; DNA CONTENT; DRUG MECHANISM; ENDOREDUPLICATION; FLOW CYTOMETRY; GENE EXPRESSION; NASOPHARYNX CARCINOMA; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

EID: 84867743723     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20867     Document Type: Article

References (28)

1. Kaestner P, Bastians H. Mitotic drug targets. J Cell Biochem 2010; 111: 258-265.
2. Finkin S, Aylon Y, Anzi S, Oren M, Shaulian E. Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy. Oncogene 2008; 27: 4411-4421.
3. Pannu V, Karna P, Sajja HK, Shukla D, Aneja R. Synergistic antimicrotubule therapy for prostate cancer. Biochem Pharmacol 2010; 81: 478-487.
4. Cantero G, Pastor N, Mateos S, Campanella C, Cortes F. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II. Mutat Res 2006; 599: 160-166.
5. Dussault N, Simard C, Neron S, Cote S. Human B lymphocytes and non-Hodgkin's lymphoma cells become polyploid in response to the protein kinase inhibitor SU6656. Blood Cells Mol Dis 2007; 39: 130-134.
6. Cortes F, Pastor N, Mateos S, Dominguez I. The nature of DNA plays a role in chromosome segregation: Endoreduplication in halogen-substituted chromosomes. DNA Repair (Amst) 2003; 2: 719-726.
7. Puig PE, Guilly MN, Bouchot A, et al. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 2008; 32: 1031-1043.
8. Shah OJ, Lin X, Li L, et al. Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization. Proc Natl Acad Sci USA 2010; 107: 12634-12639.
9. Lee AW, Tung SY, Ngan RK, et al. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer 2010; 47: 656-666.
10. Bae WK, Hwang JE, Shim HJ, et al. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol 2010; 65: 589-595.
11. Escuin D, Burke PA, McMahon-Tobin G, et al. The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression. Cell Cycle 2009; 8: 3914-3924.
12. Ting CM, Lee YM, Wong CK, et al. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways. Biochem Pharmacol 2010; 79: 825-841.
13. Huang DP, Ho JH, Poon YF, et al. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 1980; 26: 127-132.
14. Cheung ST, Huang DP, Hui AB, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999; 83: 121-126.
15. Lee YM, Ting CM, Cheng YK, et al. Mechanisms of 2-methoxyestradiol-induced apoptosis and G2/M cell-cycle arrest of nasopharyngeal carcinoma cells. Cancer Lett 2008; 268: 295-307.
16. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17: 157-162.
17. Edgar BA, Orr-Weaver TL. Endoreplication cell cycles: More for less. Cell 2001; 105: 297-306.
18. Pastor N, Cantero G, Campanella C, Cortes F. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation. Mutat Res 2005; 582: 11-19.
19. Gatti G, Maresca G, Natoli M, et al. MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel. PLoS One 2009; 4: e5442.
20. Afqir S, Ismaili N, Errihani H. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: Current status. J Cancer Res Ther 2009; 5: 3-7.
21. Mueck AO, Seeger H. 2-Methoxyestradiol-biology and mechanism of action. Steroids 2010; 75: 625-631.
22. Chua YS, Chua YL, Hagen T. Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity. Mol Cancer Ther 2010; 9: 224-235.
23. Jarnicki A, Putoczki T, Ernst M. Stat3: Linking inflammation to epithelial cancer-More than a "gut" feeling? Cell Div 2010; 5: 14.
24. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL, Su WC. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Br J Cancer 2003; 89: 344-349.
25. Ma N, Kawanishi M, Hiraku Y, et al. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR expression. Int J Cancer 2008; 122: 2517-2525.
26. Lui VW, Wong EY, Ho Y, et al. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer 2009; 125: 1884-1893.
27. Wang Z, Luo F, Li L, et al. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 2010; 46: 2996-3006.
28. Lai SY, Johnson FM. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches. Drug Resist Updat 2010; 13: 67-78.